PDCD1 and non-small cell lung carcinoma: Our findings suggest that the incorporation of PD-1/PD-L1 inhibitors alongside chemotherapy offers a promising prospect for reshaping the established treatment paradigms for patients diagnosed with resectable stages of non-small cell lung cancer.